Ligand Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. 

CEO
Todd Christopher Davis
CEOTodd Christopher Davis
Employees
47
Employees47
Headquarters
Jupiter, Florida
HeadquartersJupiter, Florida
Founded
1987
Founded1987
Employees
47
Employees47

LGND Key Statistics

Market cap
5.12B
Market cap5.12B
Price-Earnings ratio
34.52
Price-Earnings ratio34.52
Dividend yield
Dividend yield
Average volume
208.58K
Average volume208.58K
High today
$259.03
High today$259.03
Low today
$250.49
Low today$250.49
Open price
$254.99
Open price$254.99
Volume
244.57K
Volume244.57K
52 Week high
$259.03
52 Week high$259.03
52 Week low
$110.00
52 Week low$110.00

Stock Snapshot

Ligand Pharmaceuticals(LGND) stock is priced at $255.54, giving the company a market capitalization of 5.12B. It carries a P/E multiple of 34.52.

As of 2026-06-12, Ligand Pharmaceuticals(LGND) stock has fluctuated between $250.49 and $259.03. The current price stands at $255.54, placing the stock +2.0% above today's low and -1.3% off the high.

The Ligand Pharmaceuticals(LGND)'s current trading volume is 244.57K, compared to an average daily volume of 208.58K.

During the past year, Ligand Pharmaceuticals(LGND) stock moved between $110.00 at its lowest and $259.03 at its peak.

During the past year, Ligand Pharmaceuticals(LGND) stock moved between $110.00 at its lowest and $259.03 at its peak.

LGND News

TipRanks 1h
Two Ligand Pharma Insiders Just Cashed Out in Major Stock Moves

New insider activity at Ligand Pharma ( (LGND) ) has taken place on June 12, 2026. Introducing TipRanks MCP for Agents Deliver institutional-grade market data d...

Investing.com 3d
Ligand Pharmaceuticals stock hits 52-week high at $254.46 - Investing.com

...

Ligand Pharmaceuticals stock hits 52-week high at $254.46 - Investing.com
TipRanks 3d
Ligand Pharma Shareholders Back Governance and Incentive Plan

Ligand Pharma ( (LGND) ) just unveiled an announcement. At its annual stockholders’ meeting held on June 5, 2026, Ligand Pharmaceuticals’ investors approved an...

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

More LGND News

Nasdaq 6d
A Ligand Pharmaceuticals Insider Sold 5,000 Shares for $1.1 Million

Key Points 5,000 shares were sold for a total transaction value of ~$1.14 million on June 1, 2026, at a weighted average price around $227.06 per share. This...

A Ligand Pharmaceuticals Insider Sold 5,000 Shares for $1.1 Million

People also own

Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.